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 Chapter 3 
 Primer on the Gene Ontology 
 Pascale  Gaudet ,  Nives  Škunca ,  James  C.  Hu , and  Christophe  Dessimoz 
 Abstract 
 The Gene Ontology (GO) project is the largest resource for cataloguing gene function. The combination 
of solid conceptual underpinnings and a practical set of features have made the GO a widely adopted 
resource in the research community and an essential resource for data analysis. In this chapter, we provide 
a concise primer for all users of the GO. We briefl y introduce the structure of the ontology and explain 
how to interpret annotations associated with the GO. 
 Key words  Gene Ontology structure ,  Evidence codes ,  Annotations ,  Gene association fi le (GAF) ,  GO 
fi les ,  Function ,  Vocabulary ,  Annotation evidence 
1  Introduction 
 The key motivation behind the Gene Ontology (GO) was the 
observation that similar genes often have conserved functions in 
different organisms [ 1 ]. Clearly, a common vocabulary was needed 
to be able to compare the roles of orthologous genes (and their 
products) across different species. The value of comparative studies 
of biological function across systems predates Jacques Monod’s 
statement that “anything found to be true of  E. coli must also be 
true of elephants” [ 2 ]. The Gene Ontology aims to produce a rig-
orous shared vocabulary to describe the roles of genes across dif-
ferent organisms [ 1 ]. The GO project consists of the  Gene Ontology 
itself, which models biological aspects in a structured way, and 
 annotations , which associate genes or gene products with terms 
from the Gene Ontology. Combining information from all organ-
isms in one central repository makes it possible to integrate knowl-
edge from different databases, to infer the functionality of newly 
discovered genes, and to gain insight into the conservation and 
divergence of biological subsystems. 
 In this primer, we review the fundamentals of the GO project. 
The chapter is organised as answers to fi ve essential questions: 
What is the GO? Why use it? Who develops it and provides 
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 annotations? What are the elements of a GO annotation? And 
fi nally, how can the reader learn more about GO resources? 
2  What Is the Gene Ontology? 
 The Gene Ontology is a controlled vocabulary of terms to repre-
sent biology in a structured way. The terms are subdivided into 
three distinct ontologies that represent different biological aspects: 
Molecular Function (MF), Biological Process (BP), and Cellular 
Component (CC) [ 1 ]. These ontologies are non-redundant and 
share a common space of identifi ers and a well-specifi ed syntax. 
 Terms are linked to each other by relations to form a hierarchical 
vocabulary (Chap.  1 [ 3 ]). This is often modelled as a graph in which 
the relationships form the directed edges, and the terms are the 
nodes (Fig.  1 ). Since each term can have multiple relationships to 
broader parent terms and to more specifi c child terms, the structure 
allows for more expressivity than a simple hierarchy.
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 Fig. 1  The structure of the Gene Ontology (GO) is illustrated on a subset of the paths of the term “regulation of 
cell projection assembly”, GO:0060491, to its root term. The GO is a directed graph with terms as nodes and 
relationships as edges; these relationships are either is_a, part_of, has_part, or regulates. In its basic repre-
sentation, there should be no cycles in this graph, and we can therefore establish parent (more general) and 
child (more specifi c) terms (Chap.  11 [ 4 ] for more details on the different representations). Note that it is pos-
sible for a term to have multiple parents. This fi gure is based on the visualisation available from the AmiGO 
browser, generated on November 6, 2015 [ 5 ] 
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 The full GO is large: in October 2015, the full ontology specifi -
cation had 43835 terms, 73776 explicitly encoded is_a relationships, 
7436 explicitly encoded part_of relationships, and 8263 explicitly 
encoded regulates, negatively_regulates, or positively_regulates rela-
tionships. This level of detail is not necessary for all applications. 
Many research groups who do GO annotations for specifi c projects 
use the generic GO-slim fi le, which is a manually curated subset of 
the Gene Ontology containing general, high- level terms across all 
biological aspects. There are several GO slims, 1 ranging from the 
general Generic GO slim developed by the GO Consortium to more 
specifi c ones, such as the Chembl Drug Target slim. 2 
 To keep up with the current state of knowledge, as well as to 
correct inaccuracies, the GO undergoes frequent revisions: changes 
of relationships between terms, addition of new terms, or term 
removal (obsoletion). Terms are never deleted from the ontology, 
but their status changes to obsolete and all relationships to the 
term are removed [ 6 ]. Furthermore, the name itself is preceded by 
the word “obsolete” and the rationale for the obsoletion is typi-
cally found in the Comment fi eld of the term. An example of an 
obsolete term is GO:0000005, “obsolete ribosomal chaperone 
activity”. This MF GO term was made obsolete “because it refers 
to a class of gene products and a biological process rather than a 
molecular function”. 3 Changes to the  relationships do not impact 
annotations, because annotations are associated with a given GO 
term regardless of its relationships to other terms within the GO. 
Obsoletion of terms however has an impact on  annotations associ-
ated with them: in some cases, the old term can be automatically 
replaced by a new or a parent one; in others, the change is so 
important that the annotations must be manually reviewed. 
 However, these changes can affect the analyses done using the 
ontology. In articles or reports, it is good practice to provide the 
version of the fi le used for a particular analysis. In GO, the version 
number is the date the fi le was obtained from the GO site (GO fi les 
are updated daily). 
3  Why Use the Gene Ontology? 
 Because it provides a standardised vocabulary for describing gene 
and gene product functions and locations, the GO can be used to 
query a database in search of genes’ function or location within the 
cell or to search for genes that share characteristics [ 7 ]. The hierar-
chical structure of the GO allows to compare proteins annotated to 
different terms in the ontology, as long as the terms have 
1
  http://geneontology.org/page/go-slim-and-subset-guide 
2
  http://wwwdev.ebi.ac.uk/chembl/target/browser 
3
  https://www.ebi.ac.uk/QuickGO/GTerm?id=GO:0000005 
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relationships to each other. Terms located close together in the 
ontology graph (i.e. with a few intermediate terms between them) 
tend to be semantically more similar than those further apart ( see 
Chap.  12 on comparing terms [ 8 ]). 
 The GO is frequently used to analyse the results of high- 
throughput experiments. One common use is to infer common-
alities in the location or function of genes that are over- or 
under-expressed [ 6 ,  9 ,  10 ]. In functional profi ling, the GO is 
used to determine which processes are different between sets of 
genes. This is done by using a likelihood-ratio test to determine 
if GO terms are represented differently between the two gene 
sets [ 6 ]. 
 Additionally, the GO can be used to infer the function of unan-
notated genes. Gene predictions with signifi cant similarity to anno-
tated genes can be assigned one or several of the functions of the 
characterised genes. Other methods such as the presence of specifi c 
protein domains can also be used to assign GO terms [ 11 ,  12 ]. 
This is discussed in Chap.  5 [ 13 ]. 
 A wealth of tools—web-based services, stand-alone software, 
and programing interfaces—has been developed for applying the 
GO to various tasks. Some of these are presented in Chap.  11 [ 4 ]. 
 While Gene Ontology resources facilitate powerful inferences 
and analyses, researchers using the GO should familiarise them-
selves with the structure of the ontology and also with the methods 
and assumptions behind the tools they use to ensure that their 
results are valid. Common pitfalls and remedies are detailed in 
Chap.  14 [ 14 ]. 
4  Who Develops the GO and Produces Annotations? 
 The GO Consortium consists of a number of large databases 
working together to defi ne standardised ontologies and provide 
annotations to the GO [ 15 ]. The groups that constitute the GO 
consortium include UniProt [ 16 ], Mouse Genome Informatics 
[ 17 ],  Saccharomyces Genome Database [ 18 ], Wormbase [ 19 ], 
Flybase [ 20 ], dictyBase [ 21 ], and TAIR [ 22 ]. In addition, several 
other groups contribute annotations, such as EcoCyc [ 23 ] and 
the Functional Gene Annotation group at University College 
London [ 24 ]. 4 Within each group, biocurators assign annota-
tions according to their expertise [ 25 ]. Further, the GO 
Consortium has mechanisms by which members of the broader 
community ( see Chap.  7 [ 26 ]) can suggest improvements to the 
ontology and annotations. 
4
  Full list at  http://geneontology.org/page/go-consortium-contributors-list 
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5  What Are the Elements of a GO Annotation? 
 This section describes the different elements composing an anno-
tation and some important considerations about each of them. The 
annotation process from a curator standpoint is discussed in detail 
in Chap.  4 [ 27 ]. 
 Fundamentally, a GO annotation is the association of a gene 
product with a GO term. From its inception, the GO Consortium 
has recognised the importance of providing supporting infor-
mation alongside this association. For instance, annotations 
always include information about the evidence supporting the 
annotation. 
 Over time, the GO Consortium standards for storing annota-
tions have evolved to improve this representation. Annotations are 
now stored in one of the two formats: GAF (Gene Association 
File), and the more recent GPAD (Gene Product Association 
Data). The two formats contain the same information but there are 
differences in how the data is normalised and represented  (discussed 
in more details in Chap.  11 [ 4 ]). In this primer, we focus on the 
former. The representation of an annotation in the GAF fi le format 
2.1 is shown in Fig.  2 . It contains 17 fi elds (also sometimes referred 
to as “columns”). We describe them in this section.
 The annotation object is the entity associated with a GO term—a 
gene, a protein, a non-protein-coding RNA, a macromolecular 
complex, or another gene product. Seven fi elds of the GAF fi le 
specify the annotation object. Each annotation in the GO is associ-
ated with a database (fi eld 1) and a database accession number 
(fi eld 2) that together provide a unique identifi er for the gene, the 
gene product, or the complex. For example, the protein record 
P00519 is a database object in the UniProtKB database (Fig.  2 ). 
The database object symbol (fi eld 3), the database object name 
(fi eld 10), and the database object synonyms (fi eld 11) provide 
additional information about the annotation object. The database 
object type specifi es whether the object being annotated is a gene, 
or a gene product (e.g. protein or RNA; fi eld 12). The organism 
from which the annotation object is derived is captured as the 
NCBI taxon ID (taxon; fi eld 13); the corresponding species name 
can be found at the NCBI taxonomy website. 5 
 GO allows capturing isoform-specifi c data when appropriate; 
for example UniProtKB accession numbers P00519-1 and 
P00519-2 are the isoform identifi ers for isoform 1 and 2 of 
P00519. In this case, the database ID still refers to the main iso-
form, and an isoform accession is included in the GAF fi le as “Gene 
Product Form ID” (fi eld 17). 
5
  http://www.ncbi.nlm.nih.gov/taxonomy 
5.1  Annotation 
Object
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 Three fi elds are used to specify the function of the annotation 
object. Field 5 specifi es the GO term, while fi eld 9 denotes the 
sub-ontology of GO, either Molecular Function, Biological 
Process, or Cellular Component. While this information is also 
encoded in the GO hierarchy, explicitly denoting the sub-ontol-
ogy allows to simplify parsing of the annotations according to the 
GO aspect. Field 4 denotes the qualifi er. One of the three quali-
fi ers can modify the interpretation of an annotation: “contributes_
to”, “colocalizes_with” and “NOT”. This fi eld is not mandatory, 
but if present it can profoundly change the meaning of an 
5.2  GO Term, 
Annotation Extension, 
and Qualifi er
• Database from which the identifier in column 2 is derived.1. UniProtKB  {1}
• Identifier in the database denoted in column 1.2. P00519 {1}
• Database object symbol; whenever possible, this entry is assigned 
such that it is interpretable by a biologist.
3. PHO3  {1}
• Flags that modify the interpretation of an annotation. 4. NOT  {*}
• The GO identifier.5. GO:0003993  {1}
• One or more identifiers for the authority behind the annotation: e.g., 
PMID, GO Reference Code, or a database reference. 
6. PMID:2676709  
    {+}
• Evidence code; one of the codes listed in Figure 2. 7. IMP  {1}
• The content depends on the evidence code used and contains 
more information on the annotation.
8. GO:0000346  {*}
• The ontology or aspect to which the GO term in column 5 belongs to. 9. F  {1}
• Name of the gene or the gene product. 10. acid 
   phosphatase  {?}
• Synonym for the identifier denoted in column 2 for the database in 
column 1.
11. YBR092C  {*}
• The type of object denoted in column 2, e.g., gene, transcript, 
protein, or protein_structure.
12. gene  {1}
• The NCBI ID of the respective organism(s).13. taxon:4932 
      {1,2}
• Date on which the annotation was made; note that IEA annotations 
are re-calculated with every database release. 
14. 20010118  {1}
• The database asserting the annotation. 15. SGD  {1}
Zero, one, or more of: NOT (negates the 
annotation), contributes_to (when the gene 
product is part of a complex), and 
colocalizes_with (only used for the CC 
ontology). 
For single-organism terms, the NCBI 
taxonomy ID of the respective organism. For 
multi-organism terms, this column is used 
either in conjunction with a BP term that is_a
multi-organism process or CC term that is_a
host cell, in which case there are two pipe-
separated NCBI taxonomy IDs: the first 
denotes the organism encoding the gene or 
the gene product; the second denotes the 
organism in the interaction. 
C is Cellular Component, P is Biological 
Process, and M is Molecular Function. 
Different content is possible: 
- GO ID is used in conjunction with evidence 
code Inferred by Curator (IC) to denote the 
GO term from which the inference is 
made. 
- Gene product ID is used in conjunction 
with evidence codes IEA, IGI, IPI, and ISS. 
For example, in conjunction with the 
evidence code Inferred from Sequence 
Similarity (ISS), it identifies the gene 
product, similarity to which was the basis 
for the annotation. 
Any database in the GO consortium can make
inferences about any organism, so it is not 
obligatory that the field 13 corresponds to 
the field 15.
• Annotation extension. 16. part_of
     (CL:0000084) {*}
Cross references to GO or other ontologies that 
can enhance the annotation. 
• Gene Product Form ID. 17. UniProtKB:
      P00519-2   {?}
This field allows the annotation of specific 
variants of that gene or gene product. 
 Fig. 2  Gene Association File (GAF) 2.1 fi le format described with example elements. In the GAF fi le, each row 
represents an annotation, consisting of up to 17 tab-delimited fi elds (or columns). This fi gure describes these 
fi elds in the order in which they are found in the GAF fi le.  Light blue colour denotes non-mandatory fi elds, and 
these are allowed to be empty in the GAF fi le. The cardinality—the number of elements in the fi eld—is 
denoted with the symbol(s) in curly brackets: {?} indicates cardinality of zero or one; {*} indicates that any 
cardinality is allowed; {+} indicates cardinality of one or more; {1} indicates that cardinality is exactly one; {1,2} 
indicates that cardinality is either one or two. When cardinality is greater than 1, elements in the fi eld are sepa-
rated with a pipe character or with a comma; the former indicates “OR” and the latter indicates “AND”. The GO 
term assigned in column 5 is always the most specifi c GO term possible 
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annotation [ 6 ]. Thus, while the  producers of annotations may 
omit qualifi ers, applications that  consume GO annotations must 
take them into account. The importance of qualifi ers is discussed 
in more detail in Chap.  14 [ 14 ]. 
 An additional fi eld, fi eld 16, is a recent addition to combine 
more than one term or concept (protein, cell type, etc.) in the 
same annotation. For example, 6 if a gene product Slp1 is localised 
to the plasma membrane of T-cells, the GAF fi le fi eld 16 would 
contain the information “part_of(CL:0000084 T cell)”. Here, 
CL:0000084 is the identifi er for T-cell in the OBO Cell Type (CL) 
Ontology. This is covered in details in Chap.  17 [ 28 ] on annota-
tion extensions. 
 Three fi elds in the GAF fi le describe the evidence used to assert the 
annotation: the Reference (fi eld 6), the Evidence Code (fi eld 7), 
and the With/From (fi eld 8). The Evidence Code informs the type 
of experiment or analysis that supports the annotation. There are 
21 evidence codes, which can be grouped in three broad catego-
ries: experimental annotations, curated non-experimental annota-
tions, and automatically assigned (also known as electronic) 
annotations (Fig.  3 ). The Reference fi eld specifi es more details on 
the source of the annotation. For example, when the evidence code 
denotes an experimentally supported annotation, the Reference 
will contain the PubMed accession ID (or a DOI if no PubMed ID 
is available) of the journal article which underpins the annotation, 
or a GO_REF identifi er that refers to a short description of the 
assignment method, accessible on the GO website. 7 When the evi-
dence code denotes an automatically assigned annotation, i.e. IEA, 
the reference will contain GO_REF identifi ers that specify more 
details on the automatic assignment, e.g. annotation via the 
InterPro resource [ 29 ].
 Annotations based on direct experimental evidence found in the 
primary literature are denoted with the general evidence code EXP 
(Inferred from Experiment) or, when appropriate, the more spe-
cifi c evidence codes IDA (Inferred from Direct Assay), IPI (Inferred 
from Physical Interaction), IMP (Inferred from Mutant Phenotype), 
IGI (Inferred from Genetic Interaction), and IEP (Inferred from 
Expression Pattern) (Fig.  3 ). These annotations are held in high 
regard by the community, e.g. [ 30 ], and are often used in applica-
tions such as checking the enrichment of a gene set in particular 
functions, fi nding genes that perform a specifi c function, or assess-
ing involvement in specifi c pathways or processes. 
6
  http://wiki.geneontology.org/index.php/Annotation_Extension#The_basic_
format 
7
  http://www.geneontology.org/cgi-bin/references.cgi 
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 Another important use of experimentally supported annota-
tions is in providing trustworthy training sets for various computa-
tional methods that infer function [ 31 ]. Used this way, the 
experimentally supported annotations can be amplifi ed to under-
stand more of the growing set of newly sequenced genes. 
 Fourteen of the 21 evidence codes are associated with manually 
curated non-experimental annotations. Annotations associated 
with these codes are curated in the sense that every annotation is 
reviewed by a curator, but they are non-experimental in the sense 
that there is no direct experimental evidence in the primary litera-
ture underpinning them; instead, they are inferred by curators 
based on different kinds of analyses. 
 ISS (Inferred from Sequence or Structural Similarity) is a 
superclass (i.e. a parent) of ISA (Inferred from Sequence 
Alignment), ISO (Inferred from Sequence Orthology), and ISM 
(Inferred from Sequence Model) evidence codes. Each of the three 
subcategories of ISS should be used when only one method was 
used to make the inference. For example, to improve the accuracy 
of function propagation by sequence similarity, many methods take 
into account the evolutionary relationships among genes. Most of 
these methods rely on orthology (ISO evidence code), because the 
function of orthologs tends to be more conserved across species 
than paralogs [ 32 ,  33 ]. In a typical analysis, characterised and 
uncharacterised genes are clustered based on sequence similarity 
measures and phylogenetic relationships. The function of unknown 
genes is then inferred from the function of characterised genes 
within the same cluster (e.g. [ 34 ,  35 ]). 
5.3.2  Curated Non- 
experimental Annotations
Experimental
annotations (EXP)
Inferred from Direct Assay (IDA)
Inferred from Physical Interaction (IPI)
Inferred from Mutant Phenotype (IMP)
Inferred from Genetic Interaction (IGI)
Inferred from Expression Pattern (IEP)
Curated non-experimental annotations
Inferred from Sequence or Structural 
Similarity (ISS)
• Inferred from Sequence Orthology (ISO) 
• Inferred from Sequence Alignment (ISA)
• Inferred from Sequence Model (ISM)
•
•
•
•
Inferred from Biological aspect of
Ancestor (IBA)
Inferred from Biological aspect of
Descendant (IBD)
Inferred from Key Residues (IKR)
Inferred from Rapid Divergence (IRD)
Inferred from Reviewed Computational 
Analysis (RCA)
Traceable Author Statement (TAS)
Non-traceable Author Statement (NAS)
Automatically assigned
annotations
Inferred from Electronic Annotation (IEA)
Inferred from Genomic Context (IGC)
Inferred by Curator (IC)
No biological Data available (ND)
Inferred from Phylogenetic Evidence
 Fig. 3  GO Evidence Codes and their abbreviations. The type of information supporting annotations is recorded 
with Evidence Codes, which can be grouped into three main categories: experimental evidence codes, curated 
non-experimental annotations, and automatically assigned annotations. The obsolete evidence code NR (Not 
Recorded) is not included in the fi gure. Documentation about the different types of automatically assigned 
annotations can be found at  http://www.geneontology.org/doc/GO.references 
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 Another approach to function prediction entails supervised 
machine learning based on features derived from protein sequence 
[ 36 – 39 ] (ISM evidence code). Such approach uses a training set of 
classifi ed sequences to learn features that can be used to infer gene 
functions. Although few explicit assumptions about the complex 
relationship between protein sequence and function are required, 
the results are dependent on the accuracy and completeness of the 
training data. 
 IGC (Inferred from Genomic Context) includes, but is not 
limited to, such things as identity of the genes neighbouring the 
gene product in question (i.e. synteny), operon structure, and phy-
logenetic or other whole-genome analysis. 
 Relatively new are four evidence codes associated with phylo-
genetic analyses. IBA (Inferred from Biological aspect of Ancestor) 
and IBD (Inferred from Biological aspect of Descendant) indicate 
annotations that are propagated along a gene tree. Note that the 
latter is only applicable to ancestral genes. The loss of an active site, 
a binding site, or a domain critical for a particular function can be 
annotated using the IKR (Inferred from Key Residues) evidence 
code. When this code is assigned by PAINT, GO’s Phylogenetic 
Annotation and INference Tool [ 40 ], this means that it is a predic-
tion based on evolutionary neighbours. Finally, negative annota-
tions can be assigned to highly divergent sequences using the code 
IRD (Inferred from Rapid Divergence). 
 RCA (inferred from Reviewed Computational Analysis) cap-
tures annotations derived from predictions based on computa-
tional analyses of large-scale experimental data sets, or based on 
computational analyses that integrate datasets of several types, 
including experimental data (e.g. expression data, protein-protein 
interaction data, genetic interaction data), sequence data (e.g. pro-
moter sequence, sequence-based structural predictions), or math-
ematical models. 
 Next, there are two types of annotations derived from author 
statements. Traceable Author Statement (TAS) refers to papers 
where the result is cited, but not the original evidence itself, such 
as review papers. On the other hand a NAS (Non-traceable Author 
Statement) refers to a statement in a database entry or statements 
in papers that cannot be traced to another paper. 
 The fi nal two evidence codes for curated non-experimental 
annotations are IC (Inferred by Curator) and ND (No biological 
Data available). If an assignment of a GO term is made using the 
curator’s expert knowledge, concluding from the context of the 
available data, but without any  direct evidence available, the IC 
evidence code is used. For example, if a eukaryotic protein is anno-
tated with the MF term “DNA ligase activity”, the curator can 
assign the BP term “DNA ligation” and CC term “nucleus” with 
the evidence code IC. 
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 The ND evidence code indicates that the function is currently 
unknown (i.e. that no characterisation of the gene is currently 
available). Such an annotation is made to the root of the respective 
ontology to indicate which functional aspect is unknown. Hence, 
the ND evidence code allows users for a subtle difference between 
unannotated genes (for which the literature has not been com-
pletely reviewed and thus no GO annotation has been made) and 
uncharacterised genes (GO annotation with ND code). Note that 
the ND code is also different from an annotation with the “NOT” 
qualifi er (which indicates the absence of a particular function). 
 The evidence code IEA (Inferred from Electronic Annotation) is 
used for all inferences made without human supervision, regardless 
of the method used. IEA evidence code is by far the most abun-
dantly used evidence code. The guiding idea behind computational 
function annotation is the notion that genes with similar sequences 
or structures are likely to be evolutionarily related, and thus, 
assuming that they largely kept their ancestral function, they might 
still have similar functional roles today. For an in-depth discussion 
of computational methods for GO function annotations, refer to 
Chap.  5 or  see refs. [ 13 ,  41 ]. 
 Biases associated with the different evidence codes are discussed in 
Chap.  14 . Note that there is a more extensive Evidence and 
Conclusion Ontology ( ECO; [ 42 ]), formerly known as the “Evidence 
Code Ontology”, presented in Chap.  18 [ 43 ] . ECO is only partially 
implemented in the GO: ECOs are displayed in the AmiGO browser, 
but they are not in the GAF fi le. However, all Evidence Codes used 
by the GO are found also in ECO. There is a general assumption 
among the GO user community that annotations based on experi-
ments are of higher quality compared to those generated electroni-
cally, but this has yet to be empirically demonstrated. Generally, 
annotations derived from automatic methods tend to be to high-level 
terms, so they may have a lower  information value, but they often 
withstand scrutiny. Conversely, experiments are sometimes over-
interpreted ( see Chap.  4 [ 27 ]) and can also contain inaccuracies. 
 No two annotations can have the same combination of the follow-
ing fi elds: gene/protein ID, GO term, evidence code, reference, 
and isoform. Thus one gene can be annotated to the same term 
with more than one evidence code. 
 Most GO analyses are gene based, and therefore it is important in 
such analyses to make sure that the list of genes is non- redundant. 
However, annotations are often made to larger protein sets that include 
multiple proteins from the same gene. This is particularly evident in 
UniProt, which can contain distinct entries from the TrEMBL (unre-
viewed) portion of the database that do not necessarily represent bio-
logically distinct proteins. The different entries for the same protein or 
gene are often annotated with identical GO terms, which can bias 
5.3.3  Automatically 
Assigned Annotations
5.3.4  Additional 
Considerations 
About Evidence Codes
5.4  Uniqueness 
of GO Annotations (or 
Lack Thereof)
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statistical analyses because some genes have many more entries than 
other genes. For instance, the set of human proteins in UniProt com-
prises over 70,000 entries, but there are only approximately 20,000 
recognised human protein-coding genes (20,187 reviewed human 
proteins in the UniProt release of 2015_12). The GO Consortium has 
worked with UniProt as well as the Quest for Orthologs Consortium 
to develop “gene-centric” reference proteome lists ( http://www.uni-
prot.org/proteomes/ ) that provide a single “canonical” UniProt 
entry for each protein- coding gene. These lists are available for many 
species, and we encourage users performing gene-centric GO analyses 
to use only the annotations for UniProt entries in these lists. 
6  How Can I Learn More About Gene Ontology Resources? 
 Most of the topics introduced in this primer will be treated in more 
depth and nuance in later chapters. Part II focuses on the creation 
of GO function annotations—we cover in depth the two main 
strategies of creating GO function annotations: manual extrac-
tion/curation from the literature and computational prediction. 
Part III describes the main strategies used to evaluate their predic-
tive performance. Part IV covers practical uses of the GO annota-
tions: we discuss how GO terms and GO annotations can be 
summed and compared, how enrichment in specifi c GO terms can 
be analysed, and how the GO annotations can be visualised. For 
the advanced GO user, Part V discusses how the context of a GO 
annotation is recorded and goes beyond the Evidence Codes to 
describe how to capture more information on the source of an 
annotation. We end with Part VI by going beyond GO: we present 
alternatives to GO for functional annotation; we show how a struc-
tured vocabulary is used in the context of controlled clinical termi-
nologies; and we present how information from different structured 
vocabularies is integrated in one overarching resource. 
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